Literature DB >> 12898357

Clinical features and pattern of indeterminate colitis: Crohn's disease with ulcerative colitis-like clinical presentation.

Toshiyuki Matsui1, Tsuneyoshi Yao, Toshihiro Sakurai, Kenshi Yao, Fumihito Hirai, Hiroaki Matake, Sumio Tsuda, Yoko Wada, Akinori Iwashita, Sino Kamachi.   

Abstract

BACKGROUND: Although an accurate diagnosis of inflammatory bowel disease (IBD) and differentiation between ulcerative colitis (UC) and Crohn's disease (CD) can be made in most patients, it is sometimes impossible to distinguish UC from CD even after thorough pathological study. Recently, clinicians have used the term indeterminate colitis (IC) for patients with features of both diseases that overlap temporarily or persistently. The frequency, reasons, and outcome of patients with a clinical diagnosis of IC based on radiological, endoscopic, and histopathological findings were investigated retrospectively.
METHODS: Based on records of 735 patients with IBD, IC was defined as having features of both UC and CD, with differentiation from each other impossible at least once during the observation period (average 6.8 years) based on diagnostic criteria using endoscopic, radiological, and histological findings.
RESULTS: Twenty-three patients were identified as having IC. They were classified into three patterns according to the clinical course and the final diagnosis: (1) UC changing to CD (n = 8); (2) CD changing to UC (n = 5); and (3) UC or CD (n = 10). The frequency of IC was 24.5%-43.4% of colitis-type CD (n = 53), 2.3%-6.5% of all CD (n = 352), and 3.1% of IBD (n = 735). The reasons for the indetermination were temporary (56.5%) or persistent (43.5%) overlapping of UC-like and CD-like presentations. Treatment of IC was inappropriate in only two patients, and the prognoses of all patients except one were fairly good.
CONCLUSIONS: Overlapping of UC-like presentations (persistent bloody stool and diffuse colitis) was frequently observed with Crohn's colitis but less so in CD patients during their clinical course. The basis of differentiation and treatment of IC needs more attention.

Entities:  

Mesh:

Year:  2003        PMID: 12898357     DOI: 10.1007/s00535-003-1117-8

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  14 in total

1.  Evaluation of diagnostic criteria for Crohn's disease in Japan.

Authors:  Takashi Hisabe; Fumihito Hirai; Toshiyuki Matsui; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2013-04-03       Impact factor: 7.527

Review 2.  Pediatric ulcerative colitis: a practical guide to management.

Authors:  Brian P Regan; Athos Bousvaros
Journal:  Paediatr Drugs       Date:  2014-06       Impact factor: 3.022

3.  Characteristics and therapeutic efficacy of sulfasalazine in patients with mildly and moderately active ulcerative colitis.

Authors:  Qi-Kui Chen; Shi-Zheng Yuan; Zhuo-Fu Wen; Ying-Qiang Zhong; Cu-Jun Li; Hui-Sheng Wu; Can-Rong Mai; Peng-Yan Xie; Yu-Min Lu; Zhong-Lin Yu
Journal:  World J Gastroenterol       Date:  2005-04-28       Impact factor: 5.742

4.  Rectal localized giant inflammatory polyposis with indeterminate colitis.

Authors:  Takuto Ikeda; Masayuki Hotokezaka; Kazuyo Tsuchiya; Koki Nagaike; Shuichiro Uchiyama; Nobuyasu Takahashi; Hiroaki Kataoka; Kazuo Chijiiwa
Journal:  Clin J Gastroenterol       Date:  2011-03-08

5.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

6.  Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine.

Authors:  Xiao Chen; Bai-Sui Feng; Peng-Yuan Zheng; Xue-Qing Liao; Jasmine Chong; Shang-Guo Tang; Ping-Chang Yang
Journal:  Am J Pathol       Date:  2008-10-30       Impact factor: 4.307

7.  Change in the diagnosis of inflammatory bowel disease: a hospital-based cohort study from Korea.

Authors:  Ho-Su Lee; Jaewon Choe; Hyo Jeong Lee; Sung Wook Hwang; Sang Hyoung Park; Dong-Hoon Yang; Kyung-Jo Kim; Byong Duk Ye; Jeong-Sik Byeon; Seung-Jae Myung; Yong Sik Yoon; Chang Sik Yu; Jin-Ho Kim; Suk-Kyun Yang
Journal:  Intest Res       Date:  2016-06-27

8.  The utility of apoptosis inhibitor of macrophages as a possible diagnostic marker in patients with Crohn's disease.

Authors:  Yohei Ono; Shuji Kanmura; Yuko Morinaga; Kohei Oda; Katsuto Kawabata; Shiho Arima; Fumisato Sasaki; Yuichirou Nasu; Shiroh Tanoue; Shinichi Hashimoto; Hiroki Taguchi; Hirofumi Uto; Hirohito Tsubouchi; Akio Ido
Journal:  BMC Gastroenterol       Date:  2017-03-11       Impact factor: 3.067

9.  A literature-based approach for curating gene signatures in multifaceted diseases.

Authors:  Mathieu Garand; Manoj Kumar; Susie Shih Yin Huang; Souhaila Al Khodor
Journal:  J Transl Med       Date:  2020-07-10       Impact factor: 5.531

10.  Misdiagnosis and Mistherapy of Crohn's Disease as Intestinal Tuberculosis: Case Report and Literature Review.

Authors:  Jiang-Peng Wei; Xiao-Yan Wu; Sen-Yang Gao; Qiu-Yu Chen; Tong Liu; Gang Liu
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.